首页> 外文会议>International Symposium on Cancer Metastasis and the Lymphovascular system: Basis for Rational Therapy >Vascular Endothelial Growth Factors Basic Biology and Clinical Applications
【24h】

Vascular Endothelial Growth Factors Basic Biology and Clinical Applications

机译:血管内皮生长因子基础生物学和临床应用

获取原文

摘要

Vascular endothelial growth factor (VEGF)-A is a well-characterized angiogenic factor involved in physiological and pathological growth of blood vessels. The homologous tyrosine kinases VEGFR-1 and VEGFR-2 are the main VEGF-A receptors. Much evidence indicates that VEGF-A is important in tumor angiogenesis. Humanized anti-VEGF-A monoclonal antibodies and two small-molecule inhibitors of VEGF receptor signaling have been approved by the US Food and Drug Administration (FDA) for cancer therapy. Furthermore, VEGF-A is implicated in intraocular neovascularization associated with active proliferative retinopathies and the neovascular form of age-related macular degeneration (AMD).
机译:血管内皮生长因子(VEGF)-A是血管生理和病理生长的血管生成因子。同源酪氨酸激酶VEGFR-1和VEGFR-2是主要VEGF-A受体。许多证据表明VEGF-A在肿瘤血管生成中是重要的。人源化的抗VEGF-A单克隆抗体和VEGF受体信号传导的两个小分子抑制剂已被美国食品和药物管理局(FDA)批准用于癌症治疗。此外,VEGF-A涉及与活性增殖性视网膜病和年龄相关性黄斑变性(AMD)的新生血管形式相关的眼血管形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号